# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Tilray Medical, a division of Canadian cannabis giant Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Monday a new ...
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Thursday the release of premium cannabis brand, BROKEN COAST's ...
Tilray's Strategic Acquisition Will Strengthen its Craft Beer Leadership in the U.S. and Solidify Tilray Beverages as the #...
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Monday that Aphria RX GmbH has received a trading license. The new ...
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Monday that its Germany cannabis cultivation facility, Aphria RX Gm...
Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY), a global leader in cannabis research, cultivation, production, ...
Tilray Brands to release Q4 and full year 2024 results on July 29. Join the investor Q&A via Say Technologies.
The Czech Republic could follow suit and like Germany legalize the recreational use of cannabis, according to leaked documents....